Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Group 1low Concentrationhigh Volume Bupivacaine Us Guided Erector Spinae Plane Block

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Phase 2/3 (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Research Network

Common Treatments

  • Group 1low Concentrationhigh Volume Bupivacaine Us Guided Erector Spinae Plane Block1
  • Group 2high Concentrationlow Volumecbupivacaine Us Guided Erector Spinae Plane Block1

Active Sponsors

  • Norhan Abdelaleem Ali1
  • Yasmina sayed Abdrabo Ismael1
  • Cairo University1
  • Ahmed Shaker Ragab1

Top Investigators

Activity Timeline